Kissei Pharmaceutical Co., Ltd.

University Hospitals Cleveland Medical Center

Avolynt

Rosalind Franklin University of Medicine and Science, an Illinois Corporation

Bentley Cheatham

William O Wilkison

George Gorodeski

Judith Ann Potashkin

James Trinca Green

Disclosed herein are methods, sodium-dependent glucose transporter (SGLT)1 compounds and compositions for the treatment of postprandial hypoglycemia, postprandial hypoglycemia that occurs as a consequence of gastric surgery.

Method for treating post-prandial hypoglycemia

A relationship between cancer and ribonucleic acid (RNA) regulation is described by determining intracellular levels of niRN A regulators. Generally, mRNA levels are decreased in cancer cells that may be a reflection of either reduced mRNA expression and/or increased mRNA degradation. miRNAs are identified that hybridize to an mRNA that are suspected to mediate intracellular mRNA steady state levels. Alternatively, ribonucleic acid binding protein (RBP) levels may also mediate intracellular mRNA steady state levels. In particular, this invention demonstrates an effective clinical management strategy for uterine cell cancers may be implemented by taking advantage of an exemplary relationship between P2XmRNA and miRNAs including, but not limited to, miR-186 and/or miR-150.

Screening, diagnosing, treating and prognosis of pathophysiologic status by RNA regulation

Growing community of inventors

Durham, NC, United States of America

Bentley Cheatham